Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy

Journal of Cardiovascular Magnetic Resonance

Volumn 12, Issue 1, 2010, Pages

  Fluechter, Stephan ^a   Kuschyk, Jürgen ^a   Wolpert, Christian ^a   Doesch, Christina ^a   Veltmann, Christian ^a   Haghi, Dariusch ^a   Schoenberg, Stefan ^a   Sueselbeck, Tim ^a   Germans, Tjeerd ^b   Streitner, Florian ^a   Borggrefe, Martin ^a   Papavassiliu, Theano ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; DIAGNOSTIC AGENT;

ADULT; ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART STIMULATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; AGED; FIBROSIS; HEART MUSCLE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; FIBROSIS; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; RETROSPECTIVE STUDIES; RISK FACTORS; TACHYCARDIA, VENTRICULAR;

EID: 77956166153     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-12-30     Document Type: Article

References (29)

1. Efficacy of Implantable Cardioverter-Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy. Maron BJ Shen WK Epstein AE Almquist AK, Daubert JP Bardy GH, Favale S Rea RF, Boriani G Estes NA, Spirito P,, N Engl J Med 2000 342 365 373 10.1056/NEJM200002103420601 10666426
2. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Priori SG Aliot E Blomstrom-Lundqvist Bossaert L, Breithardt G Brugada P, Camm JA Cappato R, Cobbe SM Di Mario C, Maron BJ McKenna WJ, Pedersen AK Ravens U, Schwartz PJ Trusz-Gluza M, Vardas P Wellens HJ, Zipes DP,, Eur Heart J 2001 22 1374 450 10.1053/euhj.2001.2824 11482917
3. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. Monserrat L Elliott PM, Gimero JR Sharma S, Penas-Lado M McKenna WJ, J Am Coll Cardiol 2003 42 873 9 10.1016/S0735-1097(03)00827-1 12957435
4. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. Adabag AS Casey SA Kuskowski MA Zenovich AG, Maron BJ,, J Am Coll Cardiol 2005 45 697 704 10.1016/j.jacc.2004.11.043 15734613
5. "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Maron BJ Lipson LC Roberts WC Savage DD, Epstein SE,, Am J Cardiol 1978 41 1133 40 10.1016/0002-9149(78)90870-6 149494
6. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. Spirito P Bellone P, Harris KM Bernab P, Bruzzi P Maron BJ, N Engl J Med 2000 342 1778 85 10.1056/NEJM200006153422403 10853000
7. Sudden cardiac death in patients with chronic coronary heart disease. Hurwitz JL Josephson ME, Circulation 1992 85 43 49
8. Ventricular tachycardia in patients with coronary artery disease. Callans DJ Josephson ME, Cardiac Electrophysiology: From Cell To Bedside Philadelphia, Saunders, Zipes DP, Jalife J, 2000 530 536
9. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Saumarez RC Camm AJ, Panagos A Gill JS, Stewart JT de Belder MA, Simpson IA McKenna WJ, Circulation 1992 86 467 474 1638716
10. Signal-averaged electrocardiography in hypertrophic cardiomyopathy. Cripps TR Counihan PJ, Frenneaux MP Ward DE, Camm AJ McKenna WJ, J Am Coll Cardiol 1990 15 956 961 10.1016/0735-1097(90)90223-C 2312981
11. Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy. Saumarez RC Pytkowski M Sterlinski M Bourke JP, Clague JR Cobbe SM, Connelly DT Griffith MJ, McKeown PP McLeod K, Morgan JM Sadoul N, Chojnowska L Huang CL, Grace AA,, Eur Heart J 2008 29 1653 61 10.1093/eurheartj/ehn111 18385118
12. Gadolinium-Enhanced magnetic resonance imaging in hypertrophic cardiomyopathy In vivo imaging of the pathologic substrate for premature cardiac death? Kim RJ Judd RM, J Am Coll Cardiol 2003 41 1568 1572 10.1016/S0735- 1097(03)00190-6 12742299
13. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. Moon JC Reed E, Sheppard MN Elkington AG, Ho SY Burke M, Petrou M Pennell DJ, J Am Coll Cardiol 2004 43 2260 2264 10.1016/j.jacc.2004.03.035 15193690
14. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. Choudhury L Mahrholdt H Wagner A Choi KM, Elliott MD Klocke FJ, Bonow RO Judd RM, Kim RJ,, J Am Coll Card 2002 40 2156 2164 10.1016/S0735-1097(02)02602-5
15. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. Moon JC McKenna WJ, McCrohon JA Elliott PM, Smith GC Pennell DJ, J Am Coll Cardiol 2003 41 1561 1567 10.1016/S0735-1097(03)00189-X 12742298
16. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Teraoka K Hirano M, Ookubo H Sasaki K, Katsuyama H Amino M, Abe Y Yamashina A, Magn Reson Imaging 2004 22 155 61 10.1016/j.mri.2003.08.009 15010107
17. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. Adabag AS Maron BJ Appelbaum E Harrigan CJ, Buros JL Gibson CM, Lesser JR Hanna CA, Udelson JE Manning WJ, Maron MS,, J Am Coll Cardiol 2008 51 1369 74 10.1016/j.jacc.2007.11.071 18387438
18. Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia. Dimitrow PP Klimeczek P, Vliegenthart R Pasowicz M, Oudkerk M Podolec P, Tracz W Dubiel JS, Int J Cardiovasc Imaging 2008 24 77 83 10.1007/s10554-007-9209-9 17624806
19. Hypertrophic cardiomyopathy: A Systematic Review. Maron BJ, JAMA 2002 287 1308 1320 10.1001/jama.287.10.1308 11886323
20. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Maron BJ McKenna WJ Danielson GK Kappenberger LJ, Kuhn HJ Seidman CE, Shah PM Spencer WH, Spirito P Ten Cate FJ, Wigle ED,, Eur Heart J 2003 24 1965 91 10.1016/S0195-668X(03)00479-2 14585256
21. An improved MR imaging technique for the visualization of myocardial infarction. Simonetti OP Kim RJ, Fieno DS Hillenbrand HB, Wu E Bundy JM, Finn JP Judd RM, Radiology 2001 218 215 23 11152805
22. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Kellman P Arai AE, McVeigh ER Aletras AH, Magn Reson Med 2002 47 372 83 10.1002/mrm.10051 11810682
23. American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Zipes DP Camm AJ Borggrefe M Buxton AE, Chaitman B Fromer M, Gregoratos G Klein G, Moss AJ Myerburg RJ, Priori SG Quinones MA, Roden DM Silka MJ, Tracy C Priori SG, Blanc JJ Budaj A, Camm AJ Dean V, Deckers JW Despres C, Dickstein K Lekakis J, McGregor K Metra M, Morais J Osterspey A, Tamargo JL Zamorano JL, Smith SC Jr Jacobs AK, Adams CD Antman EM, Anderson JL Hunt SA, Halperin JL Nishimura R, Ornato JP Page RL, Riegel B,, Europace 2006 8 746 837 10.1093/europace/eul108 16935866
24. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Fananapazir L Chang AC, Epstein SE McAreavey D, Circulation 1992 86 730 40 1516184
25. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Schmidt A Azevedo CF, Cheng A Gupta SN, Bluemke DA Foo TK, Gerstenblith G Weiss RG, Marbn E Tomaselli GF, Lima JA Wu KC, Circulation 2007 115 2006 2014 10.1161/CIRCULATIONAHA.106.653568 17389270
26. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. Bello D Fieno DS, Kim RJ Pereles FS, Passman R Song G, Kadish AH Goldberger JJ, J Am Coll Cardiol 2005 45 1104 1108 10.1016/j.jacc.2004.12.057 15808771
27. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Nazarian S Bluemke DA, Lardo AC Zviman MM, Watkins SP Dickfeld TL, Meininger GR Roguin A, Calkins H Tomaselli GF, Weiss RG Berger RD, Lima JA Halperin HR, Circulation 2005 112 2821 2825 10.1161/CIRCULATIONAHA.105.549659 16267255
28. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Varnava AM Elliott PM Mahon N Davies MJ, McKenna WJ,, Am J Cardiol 2001 88 275 279 10.1016/S0002-9149(01)01640-X 11472707
29. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. Bondarenko O Beek AM, Hofman MB Kühl HP, Twisk JW van Dockum WG, Visser CA van Rossum AC, Journal of Cardiovascular Magnetic Resonance 2005 7 481 5 10.1081/JCMR-200053623 15881532